Lung cancer study seeks to map patient journeys
NCT ID NCT07680907
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study reviews medical records of 250 people with advanced or metastatic non-small cell lung cancer that has a specific change in the EGFR gene. Researchers want to learn about patients' backgrounds, the treatments they receive, and how well those treatments work. The goal is to better understand this group of patients and their real-world care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors better tailor treatments for people with this type of lung cancer.
What could go wrong
This is an observational study that only looks back at past data, so it cannot prove what works best. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- LungVision AI Navigation for Lung Nodule Surgery NCT07682012
- MK-7684A for Stage III NSCLC Trial (NCT05298423)
- NT-I7 + Atezolizumab for NSCLC Trial (NCT04984811)
- Imaging Agent [68Ga]Ga-DWJ155 Trial for Advanced NCT07117214
- Combination Therapy for Advanced Solid Tumors - NCT07623642
- Bone Metastasis in Lung Cancer TKI Study | NCT03958565
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••